Delinking investment in antibiotic research and development from sales revenues: the challenges of transforming a promising idea into reality
dc.contributor.author | Outterson, Kevin | |
dc.contributor.author | Gopinathan, Unni | |
dc.contributor.author | Clift, Charles | |
dc.contributor.author | So, Anthony D. | |
dc.contributor.author | Morel, Chantal M. | |
dc.contributor.author | Røttingen, John-Arne | |
dc.date.accessioned | 2017-03-02T11:50:46Z | |
dc.date.available | 2017-03-02T11:50:46Z | |
dc.date.created | 2016-11-01T14:18:16Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Nature Methods. 2016, 13 (6), . | |
dc.identifier.issn | 1548-7091 | |
dc.identifier.uri | http://hdl.handle.net/11250/2432717 | |
dc.language.iso | eng | |
dc.relation.uri | http://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002043&type=printable | |
dc.title | Delinking investment in antibiotic research and development from sales revenues: the challenges of transforming a promising idea into reality | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.source.pagenumber | 7 | |
dc.source.volume | 13 | |
dc.source.journal | Nature Methods | |
dc.source.issue | 6 | |
dc.identifier.doi | 10.1371/journal.pmed.1002043 | |
dc.identifier.cristin | 1396271 | |
cristin.unitcode | 7502,4,21,0 | |
cristin.unitcode | 7502,2,0,0 | |
cristin.unitname | Internasjonal folkehelse | |
cristin.unitname | Instituttledelse | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 |
Files in this item
This item appears in the following Collection(s)
-
Artikler [5068]
-
Publikasjoner fra CRIStin FHI [7544]